Ema: evaluation of Pfizer vaccine for 5-11 year olds "by the end of next week"

• Magrini, Aifa: from 29 November decision on vaccine for children, after Christmas the anti Covid pill

Share

November 18, 2021 "Ema evaluation of Pfizer / BioNTech's Comirnaty vaccine" for 5-11 year olds is ongoing.

A conclusion is possible by the end of next week. "

The official confirmation came today from Marco Cavaleri, head of Vaccines and Covid-19 Therapeutic Products of the European Medicines Agency, during the periodic press update.

"Covid infections are on the rise in almost all countries of the European Union and the majority" of the sick "are unvaccinated. For this reason we recommend vaccinating and for those who are eligible, to take the third dose". This is Cavaleri's appeal at the press conference. "We also encourage getting flu shots," Cavaleri added. "Preliminary data indicate that the flu vaccine can be administered in parallel with the Covid-19 vaccine."

"It is important to continue with the" anti-Covid "vaccination campaign especially in those states that have an unacceptable average of vaccinations," Cavaleri said.

"We are in the midst of the fourth wave of Covid and there are several member states" with a large portion of people over the age of 50 who are not vaccinated.

We need to close this gap ".

" We hope to have a recommendation for Molnupiravir (the anti-Covid pilla of Merck, ed) by the end of the year, "said the head of the EMA vaccination strategy.